How Value Analysis Committees’ Lines of Questioning Can Directly Affect Value Equation Outputs
John Kelty from W.L. Gore & Associates discusses how value analysis committees can determine a medical devices value when evaluating new products.
Related Resources
Webcast
In today’s value based health care market, reimbursement is tied to patient outcomes.
Webcast
AHRMM presents a four-part series on successful collaboration with suppliers.
Webcast
AHRMM presents a four-part series on successful collaboration with suppliers.
Webcast
In part two of a four-part series on successful collaboration with suppliers, Mike Schiller, former director of supply chain at AHRMM, discusses re
Webcast
It doesn’t take a deadly pandemic like Ebola to put your supply chain—and your staff and patients--at risk. Flu outbreaks cause sudden s
Webcast
Teresa Dail, chief supply chain officer, VUMC and 2018 AHRMM board chair, shares AHRMM’s definition of clinical integration and why a clinical